Enhanced Skin Penetration and Efficacy: First and Second Generation Lipoidal Nanocarriers in Skin Cancer Therapy
![Enhanced Skin Penetration and Efficacy](https://www.pharmaexcipients.com/wp-content/uploads/2024/08/Enhanced-Skin-Penetration-and-Efficacy-scaled.jpg)
Skin carcinoma remains one of the most widespread forms of cancer, and its global impact continues to increase. Basal cell carcinoma, melanoma, and squamous cell carcinoma are three kinds of cutaneous carcinomas depending upon occurrence and severity. The invasive nature of skin cancer, the limited effectiveness of current therapy techniques, and constraints to efficient systems for drug delivery are difficulties linked with the treatment of skin carcinoma.
In the present era, the delivery of drugs has found a new and exciting horizon in the realm of nanotechnology, which presents inventive solutions to the problems posed by traditional therapeutic procedures for skin cancer management. Lipid-based nanocarriers like solid lipid nanoparticles and nanostructured lipid carriers have attracted a substantial focus in recent years owing to their capability to improve the drug’s site-specific delivery, enhancing systemic availability, and thus its effectiveness.
Due to their distinct structural and functional characteristics, these nanocarriers can deliver a range of medications, such as peptides, nucleic acids, and chemotherapeutics, via different biological barriers, such as the skin. In this review, an effort was made to present the mechanism of lipid nanocarrier permeation via cancerous skin. In addition, recent research advances in lipid nanocarriers have also been discussed with the help of in vitro cell lines and preclinical studies. Being a nano size, their limitations and toxicity aspects in living systems have also been elaborated.
Read more here
Following excpients are mentioned in the study beside others: Geleol®, Cremophor® RH40, Precirol® ATO 5, Oleic acid and Cetrimide®, Tween® 80, Gelucire® 50/13, Transcutol P, Poloxamer, Labrafil M 2125 CS, Labrafil M 2130CS, Tefose 1500, Span 85, Span 20, Brij™ O10
Sharma, P., Kaul, S., Jain, N. et al. Enhanced Skin Penetration and Efficacy: First and Second Generation Lipoidal Nanocarriers in Skin Cancer Therapy. AAPS PharmSciTech 25, 170 (2024). https://doi.org/10.1208/s12249-024-02884-w
Looking for small(er) to medium production quantities of excipients?
Read more on EXCIPIO CHEMICALS here:
![Excipio Chemicals](https://www.pharmaexcipients.com/wp-content/uploads/2024/07/Excipio-Teaser-Bild-300x169.jpg)